EMN | MSCNET | BDR-WM TRIAL

BDR-WM TRIAL

This home page is related to the ongoing EMN sponsored trial:

A Phase II Study of Combination Bortezomib, Dexamethasone, and Rituximab (BDR) in previously untreated Patients with Waldenstrom's Macroglobulinemia: A multicenter Trial of the European Myeloma Network (EMN).

News


Minutes from the teleconference 20/11/2007 online
Please finde the minutes from the teleconference 20/11/2007 at the intranet part of this web page. Click at the 'log in' link in the left navigation menu.
19 Dec 2007 by BDR-WM Trial

The BDR WM trial web page is online
The home page is related to the ongoing EMN sponsored trial:

A Phase II Study of Combination Bortezomib, Dexamethasone, and Rituximab (BDR) in previously untreated Patients with Waldenstrom's Macroglobulinemia: A multicenter Trial of the European Myeloma Network (EMN).


21 Sep 2007 by BDR-WM Trial





BDR-WM TRIAL
Last Update: 21st September 2007

News management powered by Xpression News